Top 10 Companies in the Surgical Sealants Market (2026): Market Leaders Powering Global Surgery

MARKET INSIGHTS

Global surgical sealant market size was valued at USD 2.85 billion in 2024 and is projected to reach USD 4.68 billion by 2032, growing at a CAGR of 6.4% during the forecast period 2025-2032. Surgical sealants are medical products used to achieve hemostasis and tissue sealing during surgical procedures, serving as an alternative or adjunct to traditional sutures and staples.

These products are classified into two main categories: natural/biological sealants derived from human or animal proteins, and synthetic/semi-synthetic sealants made from polymer-based materials. The biological segment includes fibrin sealants and collagen-based products, while synthetic options include cyanoacrylate and polyethylene glycol-based sealants. The market growth is driven by increasing surgical procedures, rising demand for advanced wound closure techniques, and technological advancements in sealant formulations.

Key applications include cardiovascular surgery, orthopedic procedures, neurological surgeries, and general surgery. The market is characterized by strong competition among major medical device companies, with product innovation and strategic acquisitions being common strategies. Regulatory approvals and clinical evidence of efficacy remain critical factors influencing market dynamics. The COVID-19 pandemic initially impacted elective surgeries but accelerated adoption of advanced surgical technologies in the post-pandemic recovery phase.

Surgical Sealants Market – View in Detailed Research Report

---

🔟 1. Ethicon

Headquarters: New Brunswick, New Jersey, USA
Key Offering: Ethicon® Hemolock, TissuGlu, and other surgical sealants

Ethicon, a subsidiary of Johnson & Johnson, remains the market leader with a portfolio that spans cardiovascular, orthopedic, and general surgery applications. The company’s flagship products offer rapid adhesion, excellent hemostatic performance, and a low risk of allergic reactions.

Sustainability & Growth Initiatives:

• Investing in bio-based polymers to reduce carbon footprint
• Expanding global distribution in emerging markets
• Collaborating with academic centers for next‑generation sealant research

---

9️⃣ 2. Baxter International

Headquarters: Deerfield, Illinois, USA
Key Offering: CoSeal, Tisseel, and other biologic and synthetic sealants

Baxter’s broad product line covers cardiovascular, neurosurgical, and general surgery. The company focuses on integrating antimicrobial agents into its sealants to reduce postoperative infections.

Sustainability & Growth Initiatives:

• Implementing circular manufacturing processes
• Expanding R&D in hydrogel-based sealants
• Strategic acquisitions of biotech firms in the US and Europe

---

8️⃣ 3. Medtronic

Headquarters: Dublin, Ireland
Key Offering: Coseal, VascuSeal, and advanced surgical adhesives

Medtronic’s portfolio emphasizes cardiovascular and thoracic applications, with a focus on improving adhesion strength in wet tissue environments.

Sustainability & Growth Initiatives:

• Developing biodegradable sealants to reduce medical waste
• Investing in AI-driven clinical trials for faster approval
• Expanding presence in Asia‑Pacific through joint ventures

---

7️⃣ 4. Cohera Medical

Headquarters: Irving, Texas, USA
Key Offering: TissuGlu, a synthetic cyanoacrylate-based adhesive

Cohera’s TissuGlu has gained FDA approval for abdominoplasty and is expanding into cardiovascular and orthopedic indications.

Sustainability & Growth Initiatives:

• Reducing plastic waste in packaging
• Partnering with hospitals to optimize shelf life
• Launching a global marketing campaign for minimally invasive surgery

---

6️⃣ 5. Kuraray America

Headquarters: San Diego, California, USA
Key Offering: Kurasorb, a PEG‑based hydrogel sealant

Kuraray focuses on neurovascular and spinal applications, offering superior flexibility and biocompatibility.

Sustainability & Growth Initiatives:

• Investing in green chemistry for polymer synthesis
• Expanding distribution in Middle East and Africa
• Collaborating with research institutions on drug‑loaded sealants

---

5️⃣ 6. Tissuemed

Headquarters: Manchester, United Kingdom
Key Offering: Tissuemed® A and Tissuemed® B, hydrogel sealants

Tissuemed’s products are used primarily in general and orthopedic surgery, providing rapid adhesion and minimal tissue reaction.

Sustainability & Growth Initiatives:

• Developing low‑toxicity polymer blends
• Expanding presence in the EU through acquisitions
• Implementing a digital supply‑chain platform for inventory optimization

---

4️⃣ 7. B. Braun Melsungen

Headquarters: Melsungen, Germany
Key Offering: B. Braun® Surgical Sealants, including fibrin and collagen products

B. Braun offers a range of biologic sealants tailored for cardiovascular and abdominal surgery, with a focus on rapid deployment.

Sustainability & Growth Initiatives:

• Reducing single‑use plastic components
• Expanding R&D in biodegradable polymers
• Launching a European training program for surgeons

---

3️⃣ 8. CSL Behring

Headquarters: Marburg, Germany
Key Offering: Lignin‑based and fibrin sealants for cardiovascular and thoracic surgery

CSL Behring focuses on biologic sealants with high biocompatibility, targeting high‑risk surgical patients.

Sustainability & Growth Initiatives:

• Using renewable raw materials in product formulation
• Expanding presence in Asia‑Pacific markets
• Investing in clinical trials for long‑term safety data

---

2️⃣ 9. CryoLife

Headquarters: Milwaukee, Wisconsin, USA
Key Offering: CryoSeal, a cryopreserved biologic sealant for cardiac and vascular surgery

CryoLife’s products are designed for high‑pressure vascular repairs and are known for their strong adhesion under extreme conditions.

Sustainability & Growth Initiatives:

• Reducing energy consumption in cryopreservation processes
• Expanding global distribution in emerging economies
• Collaborating with universities on biomaterial research

---

1️⃣ 10. Johnson & Johnson

Headquarters: New Brunswick, New Jersey, USA
Key Offering: Ethicon® and other surgical sealants across multiple specialties

Johnson & Johnson’s portfolio spans biologic, synthetic, and hybrid sealants, offering comprehensive solutions for all surgical disciplines.

Sustainability & Growth Initiatives:

• Committing to 100% renewable energy in manufacturing
• Investing in biodegradable polymer research
• Launching a global educational initiative for surgeons

---

Download FREE Sample Report: Surgical Sealants Market – View in Detailed Research Report

Get Full Report Here: Surgical Sealants Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Surgical Sealants Is Rapidly Evolving

The surgical sealants market is set to expand from USD 2.85 billion in 2024 to an estimated USD 4.68 billion by 2032, with a 6.4% CAGR over the forecast period. By 2026, the market is projected to reach USD 3.5 billion, reflecting the accelerating adoption of minimally invasive techniques and advanced biomaterials.

📈 Key Trends Shaping the Market:

• Rapid growth of minimally invasive and robotic surgeries
• Increased regulatory focus on safety and efficacy of biologic sealants
• Expansion of drug‑delivery integrated sealants for targeted therapy
• Strategic collaborations between device manufacturers and biotech firms

As surgical technologies evolve, companies that innovate in biocompatible, biodegradable, and antimicrobial sealants will dominate market share.

---

📊 Frequently Asked Questions

What is the current market size of Global Surgical Sealants Market?

Global surgical sealants market was valued at USD 2.85 billion in 2024 and is projected to reach USD 4.68 billion by 2032.

Which key companies operate in Global Surgical Sealants Market?

Key players include Ethicon, Baxter International, Medtronic, Cohera Medical, Kuraray America, Tissuemed, B. Braun Melsungen, CSL Behring, CryoLife, and Johnson & Johnson.

What are the key growth drivers?

Increasing surgical procedures, a growing geriatric population, and demand for advanced wound closure solutions drive market growth.

Which region dominates the market?

North America is the largest market, while Asia‑Pacific is expected to grow at the highest rate during the forecast period.

What are the emerging trends?

Emerging trends include development of bioadhesive sealants, nanotechnology-based sealants, and minimally invasive surgical techniques.